Published in J Am Coll Cardiol on December 01, 1989
Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs (1991) 0.78
Diltiazem and mortality in myocardial infarction. J Am Coll Cardiol (1992) 0.75
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (2001) 4.62
The paradox of beta-adrenergic blockade in hypertension. Circulation (1968) 3.78
Mercury sphygmomanometers should not be abandoned: An advisory statement from the Council for High Blood Pressure Research, American Heart Association. Hypertension (2001) 2.20
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation (1968) 1.82
Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res (1981) 1.75
One-year longitudinal study of a no-smoking policy in a medical institution. Chest (1990) 1.75
Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med (1980) 1.73
Evaluation of the initial care of hypertensive patients. JAMA (1971) 1.64
Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med (1966) 1.57
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats: an historical account and some follow-up. Cardiovasc Res (2000) 1.49
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med (1981) 1.48
Hypertension means high blood pressure. Hypertension (1994) 1.39
Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol (1980) 1.37
Arterial pressure responses to discontinuing antihypertensive drugs. Circulation (1968) 1.37
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Pulse pressure: Is this a clinically useful risk factor? Hypertension (1999) 1.27
Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation (1970) 1.18
Tilt test for investigating a neural component in hypertension. Its correlation with clinical characteristics. Circulation (1967) 1.17
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol (1979) 1.14
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med (1969) 1.14
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol (1979) 1.13
Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension (1981) 1.13
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med (1970) 1.12
Left ventricular hypertrophy and sudden death. J Am Coll Cardiol (1998) 1.11
Regional blood flows measured in conscious rats by combined Fick and microsphere methods. Am J Physiol (1978) 1.10
A renewed call to mentor. Hypertension (2000) 1.08
Editorial: Use and abuse of diuretics. Am Heart J (1975) 1.07
Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res (1976) 1.06
Clinical-physiological correlations in the development of hypertensive heart disease. Circulation (1971) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
Plasma volume in men with essential hypertension. N Engl J Med (1968) 1.02
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension. Am J Cardiol (1976) 1.00
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension (2001) 1.00
Recent advances on large arteries in hypertension. Hypertension (1998) 1.00
Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension (1996) 0.99
Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab (1984) 0.99
Physiological comparison of labile and essential hypertension. Circ Res (1970) 0.99
Beta adrenergic blockade in the circulatory regulation of hyperkinetic states. Am J Cardiol (1971) 0.98
Recommendations for blood pressure determination by sphygmomanometry. Ann Intern Med (1988) 0.98
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol (1983) 0.97
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol (1984) 0.97
Re-examination of the hemodynamics of hypertension. Am J Med Sci (1969) 0.96
Effects of weight reduction on arterial pressure. J Chronic Dis (1982) 0.95
Total vascular pressure-volume relationship in the conscious rat. Am J Physiol (1980) 0.95
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (1978) 0.95
Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension (1997) 0.95
Electrocardiographic changes reflecting left atrial abnormality in hypertension. Circulation (1966) 0.94
Renal haemodynamic studies in obesity hypertension. J Hypertens (1987) 0.94
Cardiac output and distribution of blood volume in central and peripheral circulations in hypertensive and normotensive man. Br Heart J (1969) 0.94
Left atrial abnormality and ventricular preejection period in hypertension. Dis Chest (1969) 0.94
Immediate hemodynamic effects of urapidil in patients with essential hypertension. Am J Cardiol (1985) 0.93
Regional blood flow in normotensive and spontaneously hypertensive rats. Am J Physiol (1976) 0.93
Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension. Am J Cardiol (1985) 0.93
Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation (1981) 0.93
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension. Am J Cardiol (1983) 0.93
Devices used for self-measurement of blood pressure. Revised statement of the National High Blood Pressure Education Program. Arch Intern Med (1985) 0.93
Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension. Circulation (1978) 0.93
Plasma volume changes with long-term beta-adrenergic blockade. Am Heart J (1971) 0.92
Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR. Hypertension (1997) 0.91
The arterial system in hypertension. A prospective view. Hypertension (1995) 0.91
Stress and hypertension. J Hypertens Suppl (1990) 0.91
A hemodynamic comparison of essential and renovascular hypertension. Cardiac output and total peripheral resistance: supine and tilted patients. Circulation (1967) 0.90
Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med (1983) 0.90
Renal-splanchnic steal. Report of a case. Cleve Clin Q (1967) 0.90
Increased ANF secretion after volume expansion is preserved in rats with heart failure. Am J Physiol (1988) 0.89
Cardiac hypertrophy in hypertension. N Engl J Med (1987) 0.89
Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats. J Hypertens (1999) 0.89
Beta-blockers and mental performance. Arch Intern Med (1988) 0.88
Fluid volumes during onset of spontaneous hypertension in rats. Am J Physiol (1978) 0.88
Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy. JAMA (1969) 0.88
Can dropout and other noncompliance be minimized in a clinical trial? Report from the Veterans Administrative National Heart, Lung and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. Control Clin Trials (1982) 0.87
Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. Am J Cardiol (1981) 0.87
Arterial and venous compliance in obese and nonobese subjects. Am J Cardiol (1996) 0.87
Antihypertensive and renal effects of tienilic acid. Postgrad Med J (1979) 0.86
Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res (1973) 0.86
Comparison of hemodynamics in conscious spontaneous and renal hypertensive rats. Am J Physiol (1979) 0.86
High blood pressure. A side effect of drugs, poisons, and food. Arch Intern Med (1979) 0.86
Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume state. Am J Med (1979) 0.86
Hemodynamics of renal arterial diseases and hypertension. Am J Med Sci (1968) 0.86
Atrial natriuretic peptide increases resistance to venous return in rats. Am J Physiol (1987) 0.86
Apoptosis, coronary arterial remodeling, and myocardial infarction after nitric oxide inhibition in SHR. Hypertension (1999) 0.85
Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats. Kidney Int (1979) 0.85
Hypertension and high hematocrit. Another clue to renal arterial disease. Am J Cardiol (1966) 0.85
Arterial compliance in essential hypertension. J Cardiovasc Pharmacol (1985) 0.85
Mechanisms contributing to high blood pressure. Ann Intern Med (1983) 0.85
Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats. J Hypertens (1998) 0.85
Relation of plasma to interstitial fluid volume in essential hypertension. Circulation (1969) 0.84
Natural biventricular hypertrophy in normotensive rats. I. Physical and hemodynamic characteristics. Am J Physiol (1979) 0.84
Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy? Circulation (1987) 0.84
Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension. Circulation (1982) 0.83
"Stress" polycythemia and hypertension. JAMA (1974) 0.83
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats. Cardiovasc Res (1982) 0.82